During the past decade evidence has accumulated to support the hypothesis that the increase in alveolararterial oxygen partial pressure difference during anaesthesia is associated with an increase in airway closure secondary to a reduction in functional residual capacity (Hewlett et al., 1974a, b) . However, in a recent review Rehder and others (1977) concluded that "the suggestion that the relationship between closing capacity and functional residual capacity may underlie the impaired pulmonary gas exchange seen during anesthesia has not been clearly established and must be examined further".
The present authors have proffered an alternative hypothesis by suggesting that anaesthetic drugs may increase the blood flow to underventilated alveoli either by a direct or indirect action on the pulmonary vasculature or by depression of the pulmonary vasoconstrictor response to alveolar hypoxia (Sykes et al., 1972) . Support for this hypothesis has been provided by studies which have shown that anaesthetic concentrations of halothane, trichloroethylene, ether, methoxyflurane and nitrous oxide depress reversibly the pulmonary vasoconstrictor response to alveolar hypoxia in the isolated, perfused cat lung (Sykes et al., 1973 (Sykes et al., , 1976 Gibbs, Sykes and Tait, 1974; Hurtig, Tait and Sykes, 1977; Hurtig et al., 1977) or innervated perfused lung (Loh, Sykes and Chakrabarti, 1977) . It has been shown also that trichloroethylene 1%, ether 5% and nitrous oxide exert a similar effect in the intact dog (Sykes et al., 1975 (Sykes et al., , 1977a .
The present study was designed to investigate whether cyclopropane also depressed the vasoconstrictor response to alveolar hypoxia. perfused cat lung preparation has been utilized in order to eliminate the effects of changes in blood flow, left atrial pressure and autonomic nervous system activity on the pulmonary circulation.
METHODS
Adult cats weighing 2.2-4.5 kg were anaesthetized with sodium pentobarbitone 30-60 mg kg" 1 i.v. or i.p. Tracheotomy was performed and the lungs were ventilated with a mixture of oxygen in air delivered from a second-stage constant-volume ventilator ( fig. 1) .
A constant-flow isolated lung perfusion was then established (Sykes et al., 1973) . In this technique the lungs are perfused in situ with a constant flow of oxygenated blood at 37 °C and airway (P^y), mean pulmonary artery (Ppx) and mean left atrial (P^A) pressures are measured to enable changes in pulmonary vascular resistance (PVR) to be determined. Left atrial pressure is maintained constant at a value which maintains zone 3 conditions throughout the lungs (West, 1966) and tidal volume and functional residual capacity are held constant. If there are no changes in airway pressure, transpulmonary pressure must be constant. Since there appear to be no changes in blood viscocity (Sykes et al., 1973) any changes in pulmonary artery pressure must result from a change in pulmonary vascular resistance. Furthermore, since the lung is effectively denervated (Allison, Daly and Waaler, 1961) any changes in PVR must be caused by a direct action of the anaesthetic drug on mechanisms within the lung.
When the perfusion had been established, the lungs were ventilated with 5% carbon dioxide in air to maintain a normal Pco 2 in the perfusate. The pH was corrected to 7.3-7.4 and maintained within these limits by the addition of 4.2% sodium bicarbonate. The experimental programme was commenced when all the pressures had remained . The second-stage constantvolume ventilator aspirated the gas mixtures from Douglas bags and an end-expiratory pressure of 2 cm H 2 O was produced by passing the expired gas through a tube dipping under water. The expired gas was ducted out of the laboratory. The perfusion circuit was primed with heparinized blood and the pulsatile output from the occlusive roller pump was smoothed by the compliance created by the air in the heat exchanger and by the resistance of the screw clip on the pulmonary artery line. The left atrial pressure was maintained constant by the overflow into the left atrial reservoir.
stable for at least 10 min. First, the vasoconstrictor response to alveolar hypoxia was established by changing the ventilating gas mixture from carbon dioxide in air to 5% carbon dioxide and 3% oxygen in 92% nitrogen for a period of 3 min. The lungs were ventilated then with 5% carbon dioxide in air and when the pulmonary artery pressure had returned to the control values, a mixture of 5% cyclopropane was added to the 5% carbon dioxide in air mixture, the mixture being enriched with oxygen to ensure that an oxygen concentration close to 21% was maintained in the final mixture. The administration of cyclopropane was continued for 10 min and the hypoxic pressor response was tested by changing to a mixture containing 3% oxygen, 5% cyclopropane and 5% carbon dioxide in 87% nitrogen for 3 min. Further sequences employing 10,15, 20 and 30% cyclopropane in 21 or 3% oxygen mixtures were tested, although the 30% cyclopropane mixture was administered to only two cats. In those cats in which cyclopropane had no discernible effect on the hypoxic responses, control responses without anaesthetic were obtained only at the beginning and end of the experiment. However, when the response appeared to be depressed, intermediate responses were obtained 15 min after the cyclopropane had been withdrawn. The next concentration of cyclopropane was administered for 10 min and the response tested as before. The cyclopropane mixtures were produced by mixing carbon dioxide with 3 or 21% oxygen in nitrogen and then enriching this mixture with the amount of carbon dioxide and oxygen calculated to compensate for the subsequent dilution by cyclopropane. The appropriate cyclopropane concentration was obtained by measuring the reduction in oxygen concentration as the cyclopropane was added. All the gas analyses were made with a Hartmann-Braun URAS 4 infra-red carbon dioxide analyser and Servomex OA 101 A paramagnetic oxygen analyser.
Pulmonary vascular resistance (mm Hg per 100 ml min" 1 ) was calculated from the equation:
where Pp^ and PLA represent pulmonary atrial and left atrial pressures respectively (mm Hg), and Q = pulmonary blood flow (ml min" 1 ).
RESULTS
Of a total of 12 cats, there were 10 satisfactory perfusions. Two cats were eliminated from the study as they exhibited weak initial pressor responses to hypoxia. The details of the perfusions are shown in table I. Figure 2 shows a typical trace. Table II shows the pulmonary vascular resistance measured on the 5% carbon dioxide in air mixture before, during and after the administration of the various concentrations of cyclopropane. An analysis of variance indicated that there were no significant differences between any of the phases of the study when 21% oxygen was inspired. Table III shows the percentage increase in mean pulmonary artery pressure in response to alveolar hypoxia. Although the mean increase in pressure was reduced during the administration of cyclopropane, the differences between the means of the control responses and those obtained during the administration of 5, 10, 15 or 20% cyclopropane were not significant.
There were no changes in airway pressure during the hypoxic periods nor were there any changes during the administration of cyclopropane. However, there was a gradual increase in airway pressure throughout each perfusion which was probably associated with the accumulation of oedema as the preparation deteriorated.
DISCUSSION
These results showed that in the isolated perfused cat lung, anaesthetic concentrations of cyclopropane did not affect pulmonary vascular resistance and produced little depression of the pulmonary vasoconstrictor response to alveolar hypoxia.
Previous studies (Sykes et al., 1973 (Sykes et al., , 1976 Gibbs, Sykes and Tait, 1974) have shown that the effects of inhalation anaesthetics on the pulmonary vasoconstrictor response could be differentiated clearly from their effects on pulmonary vascular resistance. Three of the agents studied (trichloroethylene, ether and nitrous oxide) depressed the response without producing any effect on pulmonary vascular resistance whilst both halothane and methoxyflurane depressed the response and decreased pulmonary vascular resistance. Cyclopropane was tested because it has been reported to stimulate smooth muscle (McArdle and Black, 1963) and thus might have emphasized the separate actions on pulmonary vascular resistance and on the hypoxic pulmonary vasoconstrictor mechanism. Although the present experiments failed to demonstrate any significant changes it has been shown that another pulmonary vasoconstrictor, noradrenaline, reversibly depresses hypoxic pulmonary vasoconstriction in the dog (Hales and Kazemi, 1974) .
In man there is evidence that cyclopropane increases pulmonary vascular resistance (Price et al., 1969a) . It has been shown that cyclopropane increases sympathetic activity in cats (Price et al., 1969b) and it has been suggested that cyclopropane produces systemic vasoconstriction in man by releasing catecholamines (McArdle and Black, 1963) . It is therefore tempting to ascribe the changes in pulmonary vascular resistance to these mechanisms. However, Cristoforo and Brody (1968a, b) found that vasoconstriction in perfused dog grarilis muscle persisted in the presence of complete adrenergic blockade and they concluded therefore that the vasoconstriction was not mediated by the systemic or local release of catecholamines. Furthermore, Roizen and others (1976) reported that plasma concentrations of catecholamines were reduced markedly during anaesthesia with cyclopropane and that cyclopropane inhibited the veratridine-induced release of noradrenaline in the guineapig vas deferens. Another complication is that the action of cyclopropane varies with the vascular bed under study. Thus, Emerson and Massion (1967) and Dietzel, Emerson and Massion (1970) have shown that local administration increased the vascular resistance in skeletal muscle but decreased that in skin.
In all these studies the effects of species differences must be borne in mind. For example, halothane produced a marked depression of hypoxic pulmonary vasoconstriction in the cat (Sykes et al., 1973) and the rat (Bjertnaes, 1977) but no depression in the left lower lobe preparation in the dog (Benumof and Wahrenbrock, 1975) . Halothane in inspired concentrations of up to 3% also failed to diminish the pulmonary vasoconstrictor response to unilateral hypoxia in the dog (M. K. Sykes, J. M. Gibbs, L. Loh, J. Obdrzalek and R. N. Arnot, in preparation) and there is some evidence that its effect may be less marked than ether in the human (Bjertnaes et al., 1976) . Since the mechanism of the hypoxic pulmonary vasoconstrictor response is still unknown, further speculation is probably unwarranted.
